| Filed | 
                                    Name | 
                                     | 
                                    Company | 
                                    Pur. £ | 
                                    Cur. £ | 
                                    P/L % | 
                                    MPV* | 
                                
                                
                                
                                                                                                                
                                                | 
                                                    Feb '17
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Arbuthnot of Edrom
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Neuro-bio / NMS:NBIX                                                  | 
                                                
                                                    £43.24
                                                 | 
                                                
                                                    £138.04
                                                 | 
                                                                                                                                                                                                                
                                                    219.24%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £223,468.99
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '16
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Baroness Greenfield
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Neuro-bio / NMS:NBIX                                                  | 
                                                
                                                    £46.13
                                                 | 
                                                
                                                    £138.04
                                                 | 
                                                                                                                                                                                                                
                                                    199.24%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £209,468.88
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Journey Medical / NCM:DERM                                                  | 
                                                
                                                    £3.74
                                                 | 
                                                
                                                    £7.25
                                                 | 
                                                                                                                                                                                                                
                                                    93.85%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £135,695.19**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jul '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Sassoon
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Haleon / LSE:HLN.L                                                  | 
                                                
                                                    £336.10
                                                 | 
                                                
                                                    £350.80
                                                 | 
                                                                                                                                                                                                                
                                                    4.37%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £73,061.58
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '17
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Lloyd-Webber
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Hikma Pharmaceuticals / LSE:HIK.L                                                  | 
                                                
                                                    £2,026.00
                                                 | 
                                                
                                                    £1,823.00
                                                 | 
                                                                                                                                                                                                                
                                                    -10.02%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £62,986.18
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '25
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Fink
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Zoetis / NYQ:ZTS                                                  | 
                                                
                                                    £162.82
                                                 | 
                                                
                                                    £144.10
                                                 | 
                                                                                                                                                                                                                
                                                    -11.50%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £61,951.85
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Baroness Deech
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Zoetis / NYQ:ZTS                                                  | 
                                                
                                                    £168.10
                                                 | 
                                                
                                                    £144.10
                                                 | 
                                                                                                                                                                                                                
                                                    -14.28%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £60,005.95
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Evotec / NMS:EVO                                                  | 
                                                
                                                    £7.13
                                                 | 
                                                
                                                    £4.06
                                                 | 
                                                                                                                                                                                                                
                                                    -43.06%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £39,859.75
                                                    
                                                 | 
                                            
                                                                                                    
                            
                            * Minimum Potential Value based on £70,000.00 invested at time of declaration.
                            ** Interest ceased/exited on filed date.